Recital 2, Regulation (EU) 2020/1149

In forcesince 3 Aug 2020

On 6 October 2016, Germany submitted to the European Chemicals Agency (‘the Agency’) a dossier [https://echa.europa.eu/documents/10162/63c411e5-cf0f-dc5e-ff83-1e8de7e4e282] pursuant to Article 69(4) of Regulation (EC) No 1907/2006 (‘the Annex XV dossier’), in order to initiate the restriction procedure set out in Articles 69 to 73 of that Regulation. The Annex XV dossier indicated that respiratory sensitisation, due to both dermal and inhalation exposure to diisocyanates, leads to occupational asthma in workers, which has been identified as a significant occupational health problem in the Union. The annual number of new occupational diseases caused by diisocyanates (estimated to be more than 5000 cases) is considered unacceptably high. The Annex XV dossier demonstrated that action on a Union-wide basis is necessary and proposed to restrict the industrial and professional use, as well as the placing on the market, of diisocyanates on their own, and as constituent of other substances and in mixtures.